{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:40:55Z","timestamp":1762101655826},"reference-count":43,"publisher":"Portland Press Ltd.","issue":"2","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,4,15]]},"abstract":"<jats:p>Transport of the anti-cancer agent 3-bromopyruvate (3BP) in breast cancer cells is mediated by monocarboxylate transporter (MCT)-1 activated by glycosylated chaperone cluster of differentiation (CD) 147. The extracellular acidic pH increases the affinity for 3BP uptake enhancing its selective cytotoxic effect in tumour cells.<\/jats:p>","DOI":"10.1042\/bj20140921","type":"journal-article","created":{"date-parts":[[2015,2,2]],"date-time":"2015-02-02T11:59:49Z","timestamp":1422878389000},"page":"247-258","update-policy":"http:\/\/dx.doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The cytotoxicity of 3-bromopyruvate in breast cancer cells depends on extracellular pH"],"prefix":"10.1042","volume":"467","author":[{"given":"Jo\u00e3o","family":"Azevedo-Silva","sequence":"first","affiliation":[{"name":"Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal"}]},{"given":"Od\u00edlia","family":"Queir\u00f3s","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal"},{"name":"CESPU, Instituto de Investiga\u00e7\u00e3o e Forma\u00e7\u00e3o Avan\u00e7ada em Ci\u00eancias e Tecnologias da Sa\u00fade, Rua Central de Gandra, 1317, 4585-116, Gandra, PRD, Portugal"}]},{"given":"Ana","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal"}]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[{"name":"Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal"},{"name":"ICVS\/3B's - PT Government Associate Laboratory, Braga, 4710-057, Portugal"}]},{"given":"Ko H.","family":"Young","sequence":"additional","affiliation":[{"name":"KoDiscovery, LLC, University of Maryland BioPark, Suite 502 E & F, 801 West Baltimore St., Baltimore, MD 21201, U.S.A."}]},{"given":"Peter L.","family":"Pedersen","sequence":"additional","affiliation":[{"name":"Departments of Biological Chemistry and Oncology, Member at Large, Sidney Kimmel Comprehensive Cancer Center, John Hopkins University, School of Medicine, Baltimore, MD 21205-2185, U.S.A."}]},{"given":"Ana","family":"Preto","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal"}]},{"given":"Margarida","family":"Casal","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Campus de Gualtar, Braga 4710-057, Portugal"}]}],"member":"288","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"2021112216174595500_B1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2021112216174595500_B2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"2021112216174595500_B3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"2021112216174595500_B4","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1074\/jbc.M109950200","article-title":"Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis","volume":"277","author":"Pastorino","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021112216174595500_B5","doi-asserted-by":"publisher","first-page":"16918","DOI":"10.1074\/jbc.270.28.16918","article-title":"Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type\u00a0II hexokinase","volume":"270","author":"Mathupala","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021112216174595500_B6","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1038\/sj.onc.1209603","article-title":"Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria","volume":"25","author":"Mathupala","year":"2006","journal-title":"Oncogene"},{"key":"2021112216174595500_B7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12094-012-0924-x","article-title":"Novel insight into the role of GAPDH playing in tumor","volume":"15","author":"Guo","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"2021112216174595500_B8","first-page":"164","article-title":"Expression of glucose transporters in cancers","volume":"1835","author":"Szablewski","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"2021112216174595500_B9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","article-title":"Role of monocarboxylate transporters in human cancers: state of the art","volume":"44","author":"Pinheiro","year":"2012","journal-title":"J Bioenerg. Biomembr."},{"key":"2021112216174595500_B10","doi-asserted-by":"publisher","first-page":"427694","DOI":"10.1155\/2010\/427694","article-title":"Expression of monocarboxylate transporters 1, 2, and 4\u00a0in human tumours and their association with CD147 and CD44","volume":"2010","author":"Pinheiro","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"2021112216174595500_B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/abbi.1996.0186","article-title":"Functional organization of mammalian hexokinases: both N- and C-terminal halves of the rat type\u00a0II isozyme possess catalytic sites","volume":"329","author":"Tsai","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"2021112216174595500_B12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","article-title":"The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond","volume":"447","author":"Halestrap","year":"2004","journal-title":"Pflugers Arch."},{"key":"2021112216174595500_B13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/PGP.0b013e31817b5b40","article-title":"Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma","volume":"27","author":"Pinheiro","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"2021112216174595500_B14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10863-012-9408-5","article-title":"Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs)","volume":"44","author":"de Oliveira","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"2021112216174595500_B15","first-page":"1279","article-title":"GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression","volume":"26","author":"Pinheiro","year":"2011","journal-title":"Histol. Histopathol."},{"key":"2021112216174595500_B16","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/1471-2407-11-312","article-title":"Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer","volume":"11","author":"Pertega-Gomes","year":"2011","journal-title":"BMC Cancer"},{"key":"2021112216174595500_B17","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1158\/0008-5472.CAN-06-3184","article-title":"Monocarboxylate transporter 4 regulates maturation and trafficking of CD147 to the plasma membrane in the metastatic breast cancer cell line MDA-MB-231","volume":"67","author":"Gallagher","year":"2007","journal-title":"Cancer Res."},{"key":"2021112216174595500_B18","first-page":"R1824","article-title":"Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3\u00a0in the basal membrane of rat RPE","volume":"274","author":"Philp","year":"1998","journal-title":"Am. J. Physiol."},{"key":"2021112216174595500_B19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/neuonc\/nos298","article-title":"Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets","volume":"15","author":"Miranda-Goncalves","year":"2013","journal-title":"Neuro Oncol."},{"key":"2021112216174595500_B20","doi-asserted-by":"publisher","first-page":"16663","DOI":"10.1073\/pnas.1106123108","article-title":"CD147 subunit of lactate\/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors","volume":"108","author":"Le Floch","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216174595500_B21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2013.08.042","article-title":"Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-kappaB pathway","volume":"342","author":"Zhao","year":"2013","journal-title":"Cancer Lett."},{"key":"2021112216174595500_B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","article-title":"Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase","volume":"173","author":"Ko","year":"2001","journal-title":"Cancer Lett."},{"key":"2021112216174595500_B23","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1042\/BJ20080805","article-title":"Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate","volume":"417","author":"Pereira da Silva","year":"2009","journal-title":"Biochem. J."},{"key":"2021112216174595500_B24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbrc.2004.09.047","article-title":"Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP","volume":"324","author":"Ko","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021112216174595500_B25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10863-012-9417-4","article-title":"A translational study \u201ccase report\u201d on the small molecule \u201cenergy blocker\u201d 3-bromopyruvate (3BP) as a potent anticancer agent: from bench side to bedside","volume":"44","author":"Ko","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"2021112216174595500_B26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/ng.2471","article-title":"MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors","volume":"45","author":"Birsoy","year":"2013","journal-title":"Nat. Genet."},{"key":"2021112216174595500_B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10863-012-9418-3","article-title":"Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate","volume":"44","author":"Queiros","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"2021112216174595500_B28","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1002\/cncr.24532","article-title":"Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate","volume":"115","author":"Thangaraju","year":"2009","journal-title":"Cancer"},{"key":"2021112216174595500_B29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2133\/dmpk.19.363","article-title":"Mechanism of L-lactic acid transport in L6 skeletal muscle cells","volume":"19","author":"Kobayashi","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"key":"2021112216174595500_B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1042\/BJ20091515","article-title":"AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10","volume":"425","author":"Ovens","year":"2010","journal-title":"Biochem. J."},{"key":"2021112216174595500_B31","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2021112216174595500_B32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/CAD.0000000000000094","article-title":"Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy","volume":"25","author":"Majkowska-Skrobek","year":"2014","journal-title":"Anticancer Drugs"},{"key":"2021112216174595500_B33","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.1073\/pnas.1430846100","article-title":"SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers","volume":"100","author":"Li","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216174595500_B34","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","article-title":"CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression","volume":"19","author":"Kirk","year":"2000","journal-title":"EMBO J."},{"key":"2021112216174595500_B35","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1074\/jbc.M113.537043","article-title":"Intracellular and extracellular carbonic anhydrases cooperate non-enzymatically to enhance activity of monocarboxylate transporters","volume":"289","author":"Klier","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2021112216174595500_B36","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1073\/pnas.1014293108","article-title":"Intramolecular proton shuttle supports not only catalytic but also noncatalytic function of carbonic anhydrase II","volume":"108","author":"Becker","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021112216174595500_B37","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1017\/S0007114512001948","article-title":"A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate","volume":"108","author":"Fung","year":"2012","journal-title":"Br. J. Nutr."},{"key":"2021112216174595500_B38","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol. Cell"},{"key":"2021112216174595500_B39","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1091\/mbc.E04-05-0402","article-title":"Links between CD147 function, glycosylation, and caveolin-1","volume":"15","author":"Tang","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"2021112216174595500_B40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting proton dynamics and energy metabolism for cancer therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2021112216174595500_B41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10585-008-9195-x","article-title":"Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization","volume":"25","author":"Vossen","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"2021112216174595500_B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.trsl.2011.08.008","article-title":"Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma","volume":"159","author":"Schaefer","year":"2012","journal-title":"Transl. Res."},{"key":"2021112216174595500_B43","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/mrm.24355","article-title":"EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate","volume":"69","author":"Matsumoto","year":"2013","journal-title":"Magn. Reson. Med."}],"container-title":["Biochemical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/467\/2\/247\/682977\/bj4670247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemj\/article-pdf\/467\/2\/247\/682977\/bj4670247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T23:05:04Z","timestamp":1637622304000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemj\/article\/467\/2\/247\/48506\/The-cytotoxicity-of-3-bromopyruvate-in-breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4,15]]}},"URL":"https:\/\/doi.org\/10.1042\/bj20140921","relation":{},"ISSN":["0264-6021","1470-8728"],"issn-type":[{"value":"0264-6021","type":"print"},{"value":"1470-8728","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]}}}